MONTREAL, CANADA--(Marketwired - May 21, 2014) - Theratechnologies Inc. (TSX:TH) today held its annual meeting of shareholders, chaired by Dawn Svoronos, chair of the board of Theratechnologies.
At the meeting, the following people were elected as company directors by a majority of the votes.
| FOR | % FOR | ABSENTION | % ABSTENTION | ||
| Gilles Cloutier | 13,698,862 | 97.19 | 396,538 | 2.81 | |
| Gérald A. Lacoste | 13,966,512 | 99.09 | 128,888 | 0.91 | |
| Paul Pommier | 13,692,362 | 97.14 | 403,038 | 2.86 | |
| Dawn Svoronos | 14,031,415 | 99.55 | 63,985 | 0.45 | |
| Jean-Denis Talon | 13,964,013 | 99.07 | 131,387 | 0.93 | |
| Luc Tanguay | 14,059,815 | 99.75 | 35,585 | 0.25 |
At the meeting, KPMG was appointed as auditors of the Corporation.
About Theratechnologies
Theratechnologies (TSX:TH) is a specialty pharmaceutical company addressing unmet medical needs in metabolic disorders to promote healthy ageing and improved quality of life. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on the SEC's website at www.sec.gov.
Contact Information:
514-843-2393